Loading organizations...
SB Life Science operates as an investment firm, funding and developing companies within healthcare and life sciences. Advising SB Life Science Ventures I, L.P., a venture capital fund, it applies expertise in venture capital, management consulting, and hospital administration. The firm specializes in cross-border business development, supporting companies targeting Asian markets.
Established in 2001, based in Palo Alto, SB Life Science was founded on the insight that specialized capital and strategic guidance are crucial for global life sciences expansion. Its genesis provided support for innovative healthcare ventures, helping them capitalize on international opportunities, particularly within Asian economies.
The firm partners with innovative life science and healthcare companies needing capital and tailored market access. SB Life Science’s vision is to be a leading facilitator, fostering their growth and market penetration. It leverages its distinctive network and support from Japanese institutional investors to unlock new opportunities across Asia.
SB Life Science Ventures has 1 tracked investment across 1 company. The latest tracked deal is $30.0M Series D in CircuLite in November 2011.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 1, 2011 | CircuLite | $30.0M Series D | Eric A. Rose | Forbion, Credit Agricole Private Equity, Foundation Medical Partners, Saints Capital |
